NVS logo

Novartis AG (NVS) Current Assets

Annual Current Assets

$30.48 B
-$6.43 B-17.42%

31 December 2023

NVS Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$31.26 B
+$5.57 B+21.68%

30 September 2024

NVS Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVS Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-17.4%-31.5%
3 y3 years+2.7%+19.1%
5 y5 years-14.3%+17.2%

NVS Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-33.3%+2.7%-31.6%+21.7%
5 y5 years-33.3%+3.3%-31.6%+40.8%
alltimeall time-33.3%+49.4%-40.4%+100.2%

Novartis AG Current Assets History

DateAnnualQuarterly
Sept 2024
-
$31.26 B(+21.7%)
June 2024
-
$25.69 B(-2.9%)
Mar 2024
-
$26.45 B(-13.2%)
Dec 2023
$69.46 B(-13.8%)
$30.48 B(-33.2%)
Sept 2023
-
$45.66 B(+36.3%)
June 2023
-
$33.49 B(+4.3%)
Mar 2023
-
$32.11 B(-13.0%)
Dec 2022
$80.54 B(-6.4%)
$36.91 B(-0.1%)
Sept 2022
-
$36.95 B(-3.1%)
June 2022
-
$38.14 B(+2.4%)
Mar 2022
-
$37.24 B(-18.6%)
Dec 2021
$86.08 B(-12.3%)
$45.72 B(+74.1%)
Sept 2021
-
$26.25 B(+10.3%)
June 2021
-
$23.81 B(+7.3%)
Mar 2021
-
$22.20 B(-25.2%)
Dec 2020
$98.11 B(+10.4%)
$29.67 B(+2.4%)
Sept 2020
-
$28.97 B(+21.3%)
June 2020
-
$23.88 B(+3.4%)
Mar 2020
-
$23.10 B(-21.7%)
Dec 2019
$88.87 B(-19.2%)
$29.50 B(+10.6%)
Sept 2019
-
$26.68 B(-5.8%)
June 2019
-
$28.32 B(-46.0%)
Mar 2019
-
$52.45 B(+47.5%)
Dec 2018
$110.00 B(+4.9%)
$35.56 B(+4.3%)
Sept 2018
-
$34.11 B(+6.4%)
June 2018
-
$32.06 B(-3.0%)
Mar 2018
-
$33.05 B(+17.2%)
Dec 2017
$104.87 B(-0.3%)
$28.21 B(+2.7%)
Sept 2017
-
$27.47 B(+3.5%)
June 2017
-
$26.54 B(+3.0%)
Mar 2017
-
$25.77 B(+3.3%)
Dec 2016
$105.19 B(-3.2%)
$24.93 B(-3.7%)
Sept 2016
-
$25.88 B(+9.1%)
June 2016
-
$23.72 B(+3.2%)
Mar 2016
-
$22.99 B(+0.6%)
Dec 2015
$108.71 B(+23.8%)
$22.84 B(-5.0%)
Sept 2015
-
$24.05 B(-2.8%)
June 2015
-
$24.75 B(-3.7%)
Mar 2015
-
$25.71 B(-31.6%)
Dec 2014
$87.83 B(-8.2%)
$37.56 B(+2.1%)
Sept 2014
-
$36.79 B(+5.2%)
June 2014
-
$34.97 B(+17.8%)
Mar 2014
-
$29.69 B(-2.8%)
Dec 2013
$95.71 B(-0.5%)
$30.54 B(+6.2%)
Sept 2013
-
$28.77 B(+7.2%)
June 2013
-
$26.84 B(+0.2%)
Mar 2013
-
$26.80 B(-4.3%)
Dec 2012
$96.19 B
$28.00 B(+7.1%)
DateAnnualQuarterly
Sept 2012
-
$26.15 B(+0.1%)
June 2012
-
$26.12 B(+1.3%)
Mar 2012
-
$25.79 B(+7.1%)
Dec 2011
$93.41 B(-3.3%)
$24.08 B(-5.8%)
Sept 2011
-
$25.56 B(-4.0%)
June 2011
-
$26.63 B(-8.5%)
Mar 2011
-
$29.10 B(+9.1%)
Dec 2010
$96.63 B(+56.3%)
$26.68 B(-3.7%)
Sept 2010
-
$27.72 B(-28.3%)
June 2010
-
$38.67 B(+8.0%)
Mar 2010
-
$35.80 B(+6.3%)
Dec 2009
$61.81 B(+7.7%)
$33.69 B(+10.7%)
Sept 2009
-
$30.44 B(+12.0%)
June 2009
-
$27.17 B(+20.9%)
Mar 2009
-
$22.48 B(+7.7%)
Dec 2008
$57.42 B(+19.6%)
$20.88 B(-10.4%)
Sept 2008
-
$23.30 B(-27.4%)
June 2008
-
$32.09 B(+22.1%)
Mar 2008
-
$26.29 B(-4.2%)
Dec 2007
$48.02 B(+3.0%)
$27.43 B(-4.4%)
Sept 2007
-
$28.68 B(+39.0%)
June 2007
-
$20.64 B(-3.3%)
Mar 2007
-
$21.33 B(-0.3%)
Dec 2006
$46.60 B(+28.4%)
$21.40 B(+2.1%)
Sept 2006
-
$20.97 B(+6.0%)
June 2006
-
$19.80 B(-9.7%)
Mar 2006
-
$21.91 B(+2.2%)
Dec 2005
$36.29 B(+27.0%)
$21.44 B(+16.1%)
Sept 2005
-
$18.48 B(-8.1%)
June 2005
-
$20.11 B(-9.7%)
Mar 2005
-
$22.26 B(-6.9%)
Dec 2004
$28.57 B(+5.6%)
$23.92 B(+11.0%)
Sept 2004
-
$21.56 B(-0.3%)
June 2004
-
$21.63 B(+2.0%)
Mar 2004
-
$21.21 B(-4.8%)
Dec 2003
$27.04 B(+11.7%)
$22.27 B(+8.6%)
Sept 2003
-
$20.52 B(+1.8%)
June 2003
-
$20.16 B(-7.9%)
Mar 2003
-
$21.88 B(+5.1%)
Dec 2002
$24.21 B(+23.1%)
$20.82 B(+14.8%)
Sept 2002
-
$18.12 B(-12.7%)
June 2002
-
$20.75 B(+0.6%)
Dec 2001
$19.66 B(+25.7%)
$20.64 B(+32.2%)
June 2001
-
$15.62 B(-23.5%)
Dec 2000
$15.65 B(-19.2%)
$20.41 B(-12.1%)
June 2000
-
$23.22 B
Dec 1999
$19.37 B(+1.4%)
-
Dec 1998
$19.09 B
-

FAQ

  • What is Novartis AG annual total current assets?
  • What is the all time high annual current assets for Novartis AG?
  • What is Novartis AG annual current assets year-on-year change?
  • What is Novartis AG quarterly total current assets?
  • What is the all time high quarterly current assets for Novartis AG?
  • What is Novartis AG quarterly current assets year-on-year change?

What is Novartis AG annual total current assets?

The current annual current assets of NVS is $30.48 B

What is the all time high annual current assets for Novartis AG?

Novartis AG all-time high annual total current assets is $45.72 B

What is Novartis AG annual current assets year-on-year change?

Over the past year, NVS annual total current assets has changed by -$6.43 B (-17.42%)

What is Novartis AG quarterly total current assets?

The current quarterly current assets of NVS is $31.26 B

What is the all time high quarterly current assets for Novartis AG?

Novartis AG all-time high quarterly total current assets is $52.45 B

What is Novartis AG quarterly current assets year-on-year change?

Over the past year, NVS quarterly total current assets has changed by -$14.40 B (-31.53%)